FDA Approves Bondlido (lidocaine topical system) for the Treatment of Post-Herpetic Neuralgia

Sep 30, 2025 - 02:00
 0  0
September 25, 2025 -- MEDRx announced that the U.S. Food and Drug Administration (FDA) has approved Bondlido, a lidocaine*1 patch MEDRx Group and D. Western Therapeutics Institute, Inc. has jointly developed, in adults for relief of pain associated...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0